IP Library › Assignment 021029/0922
Patent Assignment
Reel/Frame 021029/0922

Change of Name

Recorded: 2008-06-04 Pages: 4
Assignor
GEMINX BIOTECHNOLOGIES INC.
Executed: 2007-12-28
Assignee
GEMINX PHARMACEUTICALS CANADA INC.
3576 AVE. DU PARC, SUITE 4310, MONTREAL, QUEBEC, H2X 2H7, CANADA
Covered Properties (3)
Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Patent: 6,407,244 →
Application: 09/491,712 →
Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Patent: 6,602,879 →
Application: 10/116,094 →
Publication: US 2003/0009032
Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer, Treating Viral Diseases and Causing Immunosuppression
Patent: 7,144,912 →
Application: 10/484,652 →
Publication: US 2005/0049292
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Jul 19, 2004
From: GEMINX BIOTECHNOLOGIES, INC.
To: INVESTISSEMENT QUEBEC
Reel/Frame 015579/0253 →
Assignment of Assignor's Interest Jul 26, 2004
From: SHORE, GORDON C.; MURTHY, MADIRAJU S.R.; ATTARDO, GIORGIO; JOHNSON, ROY A.
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 015613/0324 →
Release of Security Interest Jun 5, 2012
From: INVESTISSEMENT QUEBEC
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 028320/0312 →